Actualizado 21/05/2009 15:03
- Comunicado -

Lilly Advances Second Alzheimer's Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials (y

iv. Wimo A., Winblad B., Jonsson L. An estimate of the total worldwide societal costs of dementia in 2005 (2007) Alzheimer's and Dementia, 3 (2), pp. 81-91

P--LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

Jamaison Schuler for Lilly, APR, mobile, +1-317-847-9617; Photo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO

Contenido patrocinado